Manufacturing is just one part of the vaccine ecosystem. It’s the health system that delivers vaccines and people must be willing to take them.
Laws and rituals surrounding disease have been part of everyday life for millennia. Here’s why that’s important.
As international borders open, restrictions ease and we mingle with others, we can expect more germs to circulate.
Researchers asked aid workers how to best prepare for the climate emergency in places where its effects are most severe.
Ivermectin has been a lifesaving drug for people with parasitic infections like river blindness and strongyloidiasis. But taking it for COVID-19 may result in the opposite effect.
Recent computer modeling shows the upcoming flu season might see a surge in cases. Coupled with COVID-19’s continued threat, doctors are again urging Americans to get their shots.
Since the coronavirus first began spreading around the globe, people have debated how effective masks are at preventing COVID-19. A year and a half in, what does the evidence show?
When the coronavirus copies itself, there is a chance its RNA will mutate. But new variants must jump from one host to another, and the more infections there are, the better chance this will happen.
An infectious disease doctor explains the science behind COVID-19 vaccines at a level that children – and adults – of all ages can understand.
A 2015 paper on chicken virus evolution is being taken out of context and used to fuel fears about COVID-19 vaccines. Its lead author aims to clarify the science in hopes of saving lives.
New research shows correctional officers are vectors of infection, driving COVID-19 rates both inside prisons and in their communities.
Researchers are piecing together clues to better understand the puzzling array of symptoms in those who never seem to fully recover from COVID-19.
Different groups of researchers give different predictions. And it’s easy to be bewildered, especially if you’re in lockdown and looking for answers. Here’s what to make of it all.
COVID has shown us we can develop a range of safe and effective vaccines. Now we need to do the same for TB.
Policymakers need to make sense of the data so as to predict and manage what’s happening. To address this need, we developed a visualisation tool to track and predict country-level COVID-19 cases.
It’s still reasonably easy to catch a cold even during lockdown.
BCG remains the only widely available vaccine for TB. Yet the development of a COVID-19 vaccine over the last year shows that there is capacity to rapidly create new vaccines.
The microbiologist who directs the National Emerging Infectious Diseases Laboratories at Boston University explains all the biosafety precautions in place that help him feel safer in the lab than out.
Scientists get up close and personal with deadly pathogens to give doctors the tools they need to treat people sickened by germs. The key is keeping the researchers – and everyone around them – safe.
The Gambia’s success in eliminating trachoma means that resources previously allocated to combating the disease can now be reallocated to other public health conditions